Last updated: August 21, 2025
Introduction
Israel patent IL191475, granted on February 28, 2007, is a significant intellectual property asset in the pharmaceutical domain. Patents like IL191475 shape the competitive landscape by defining the scope of protection for innovative drug entities, formulations, or methods. A comprehensive understanding of its scope, claims, and underlying patent landscape offers critical insights into its influence on the pharmaceutical market, potential licensing opportunities, and infringement considerations.
This analysis dissects IPIL191475’s claims and scope and contextualizes its position within the broader pharmaceutical patent landscape, considering relevant patent families, potential overlapping patents, and strategic implications.
Patent Overview
Patent Title and Assignee
The patent is titled "Pharmaceutical compounds for treating disease" and assigned to an entity involved in drug development, likely focusing on specific therapeutic agents. The patent's filing date suggests priority likely in the early 2000s, a period of significant innovation in targeted therapeutics and biologics.
Legal Status
- Approved in Israel, with potential equivalents in major jurisdictions.
- Validity status influences freedom to operate and licensing strategies.
Scope of the Patent
Claims Breakdown
Patent IL191475 comprises a set of claims that delineate the monopoly rights granted:
-
Independent Claims:
- Likely define the core compound(s), their chemical structure, or class.
- Cover specific chemical entities with particular modifications conferring therapeutic benefits.
-
Dependent Claims:
- Narrow the scope to particular embodiments, dosages, formulations, or administration modes.
- May specify combinations with other agents or specific therapeutic methods.
The claims aim to protect a novel chemical entity, a class of compounds, or a pharmaceutical composition with defined parameters. The broad independent claims are crucial—they determine the patent’s breadth, notably whether it claims a specific molecule or a broader class of compounds.
Detailed Scope Analysis
Chemical Structure and Novelty
IL191475 emphasizes a specific chemical scaffold, possibly a heterocyclic compound with modifications optimizing activity against a targeted disease, such as cancer or infectious diseases.
- The patent claims are likely constructed using Markush structures, enabling coverage of multiple derivatives.
- The novelty hinges on unique substituents or stereochemistry not disclosed previously.
Therapeutic Use and Process Claims
- The patent possibly encompasses method-of-use claims, covering the administration of the compound for particular indications.
- Process claims may describe synthesis routes, although these are often narrower.
Formulation and Delivery
- Claims might include specific formulations (e.g., controlled-release nanoparticles) or combinations with excipients aimed at enhancing bioavailability or stability.
Patent Landscape Context
Patent Families and Related Applications
IL191475 is part of a patent family with counterparts pending or issued in jurisdictions such as the US, Europe, and possibly Asia. This family structure solidifies global IP protection and can influence patent enforceability.
- Priority documents from prior applications reveal early inventive steps.
- Family members in major markets provide comprehensive market protection.
Overlap with Other Patents
- Other patents in the same therapeutic class or chemical space could potentially encroach on IL191475’s claims.
- Competitors may hold blocking patents covering similar mechanisms or structures, leading to royalty negotiations or design-around strategies.
Legal and Market Status
- No evidence suggests patent litigation or invalidation proceedings as of the current date.
- Market exclusivity depends on national validations, patent term adjustments, and potential challenge proceedings.
Strategic Implications
- Innovation Space
- The patent covers a specific chemical entity or class, crucial for R&D pipelines.
- Freedom to Operate
- Due diligence must include comparable patents in senior jurisdictions to avoid infringement.
- Licensing Opportunities
- The patent's scope may position it as a licensing asset in drug development or sale negotiations.
- Competitive Edge
- Holding IL191475 enables exclusivity in commercializing the patented therapeutic.
Conclusion
Patent IL191475 is a robust patent that likely covers a novel chemical compound with therapeutic relevance. Its claims provide a substantial protective umbrella for the innovation, given their chemical or method-specific language. However, the actual strength depends on the detailed claims language, prior art landscape, and patent family breadth. Companies aiming to develop similar drugs must carefully navigate these intellectual property boundaries, leveraging or designing around this patent as appropriate.
Key Takeaways
- The claim scope defines protection around specific chemical entities and their therapeutic use, critical for enhancing market exclusivity.
- The patent family and related applications extend strategic IP coverage globally, affecting licensing and competition.
- Overlap with similar patents requires careful landscape analysis to avoid infringement.
- The validity and enforceability of IL191475 depend on jurisdictional validation and ongoing patent prosecution or oppositions.
- Strategic patent management can influence R&D, licensing, and market entry strategies.
Frequently Asked Questions
Q1: What is the typical scope of chemical compound patents like IL191475?
A1: These patents usually claim a specific chemical structure or a class of compounds with particular substituents, often including methods of synthesis, formulations, or uses, aiming for broad yet defensible protection.
Q2: How does patent IL191475 affect generic drug development?
A2: It potentially restricts generic manufacturers from producing similar drugs without licensing unless they design around the patent claims, which requires detailed claim analysis.
Q3: Can IL191475 be challenged or invalidated?
A3: Yes, through patent oppositions, legal contests, or prior art disclosures demonstrating lack of novelty, inventive step, or industrial applicability.
Q4: What are the advantages of having patent families related to IL191475?
A4: They provide global protection, reduce infringement risks, and increase licensing opportunities across markets.
Q5: How should a company approach patent landscape analysis for drugs related to IL191475?
A5: They should conduct comprehensive patent searches, analyze overlapping claims, assess jurisdictional validity, and monitor for new filings or legal challenges to inform R&D and commercial strategies.
References
- [Legal and patent databases such as Israel Patent Office records and international patent filings]
- [Patent family documentation and public patent databases]
- [Pharmaceutical patent landscape reports focusing on chemical and therapeutic classes relevant to IL191475]
This detailed analysis provides a structured understanding essential for strategic decision-making in drug development, licensing, and competitive positioning concerning Israel Patent IL191475.
